Physician

Mirza T Hamirani, M.D.

According to 2025 Medicare claims, Mirza Hamirani, M.D. (NPI: 1861460099) practices nephrology in the Parkersburg-Vienna, WV market, with the plurality of this provider's patient population coming from Wood, WV. This provider's primary affiliated billing organization is MID-OHIO VALLEY NEPHROLOGY ASSOCIATION (NPI: 1073903373; TIN: 371450029) and primary practice location at 26105-4100. Hamirani is affiliated with the ACO West Virginia (ACO ID: A3563) and Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Hamirani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 576 traditional Medicare patients, billed 3,136 HCPCS/CPT codes, and received $292,819 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,728 prescription claims across 535 beneficiaries totaling $479,786 in drug costs, led by Xphozah (Tenapanor Hcl). 2021 DME data shows 41 claims. Open Payments data shows 70 records totaling $1,167. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $586,684 to $292,819. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,303,707 to $479,786. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,490	6,498	$586,684
2016	1,521	7,415	$660,525
2017	1,470	7,269	$613,805
2018	1,424	7,185	$682,437
2019	1,434	7,351	$704,830
2020	1,212	6,277	$593,745
2021	1,045	5,129	$521,691
2022	742	3,157	$302,873
2023	542	2,483	$252,810
2024	576	3,136	$292,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	934	9,601	$1,303,707
2016	967	9,443	$1,263,421
2017	912	8,787	$1,407,369
2018	854	7,437	$1,048,550
2019	897	6,219	$676,252
2020	731	4,203	$538,280
2021	689	4,008	$448,489
2022	660	3,747	$385,816
2023	615	3,968	$439,508
2024	535	2,728	$479,786

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$263
2020	N/R	24	$753
2021	N/R	41	$1,089
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	120	171	$122
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	76	95	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	406	922	$86
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	120	684	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	86	400	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	29	1,620	$154,174
Renvela	Sevelamer Carbonate	11	630	$50,931
Veltassa	Patiromer Calcium Sorbitex	29	1,256	$50,039
Sevelamer Carbonate	Sevelamer Carbonate	124	5,109	$29,397
Prosol	Parenteral Amino Acid 20% No.1	116	797	$18,524

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	70	$1,167	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mirza T. Hamirani, M.D.?

Tedicare shows public-source Medicare data for Mirza T. Hamirani, M.D. (NPI 1861460099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mirza T. Hamirani, M.D. have ACO affiliation data?

Mirza T. Hamirani, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to Mirza T. Hamirani, M.D.?

Mirza T. Hamirani, M.D. is linked to MID-OHIO VALLEY NEPHROLOGY ASSOCIATION (billing NPI 1073903373) in the available physician profile data.

Does Mirza T. Hamirani, M.D. have Open Payments data?

Mirza T. Hamirani, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.